Abstrait
Ľincidence des hémopathies augmente depuis deux décennies. Ainsi ľincidence des lymphomes est passée, entre 1980 et 2000, de 7 à 15 nouveaux cas pour 100 000 habitants et par an. Les méthodes diagnostiques sont de plus en plus performantes. Le pronostic de ces hémopathies s’est considérablement amélioré et ľinvestissement thérapeutique est donc de plus en plus important. Enfin, le vieillissement de la population entraîne ľémergence de nouvelles hémopathies malignes, comme les syndromes myéloprolifératifs. De nombreux facteurs contribuent donc à ľaugmentation ďincidence des hémopathies malignes, et tout, contribue à ce qu’elles soient traitées de façon plus agressive avec un espoir de rémission complète beaucoup plus important. Les lignes de chimiothérapie peuvent se succéder pour maintenir la rémission, chez des patients de plus en plus âgés, et dont ľétat général peut s’être altéré au cours des traitements.
Preview
Unable to display preview. Download preview PDF.
Références
Raynard B, Nitenberg G, Gory-Delabaere G, et al. (2002) Standards, options et recommandations pour la nutrition artificielle au cours et au décours des greffes de cellules souches hématopoïétiques. Bull Cancer 89: 381–98
Raynard B, Nitenberg G, Gory-Delabaere G, et al. (2003) Summary of the Standards, Options and Recommendations for nutritional support in patients undergoing bone marrow transplantation (2002). Br J Cancer 89 Suppl 1: S101–6
Muscaritoli M, Grieco G, Capria S, et al. (2002) Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 75: 182–90
Murray SM, Pindoria S, (2002) Nutrition support for bone marrow transplant patients. Cochrane Database Syst Rev (2): CD002920
Dewys WD, Begg C, Lavin PT, et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69: 491–7
Rossignol G, Meuric J, Dupoiron D, et al. (2005) Prévalence et dépistage de la dénutrition en cancérologie. Nutr Clin Metabol 19 (suppl 1): S73
Deeg HJ, Seidel K, Bruemmer B, et al. (1995) Impact of patient weight on non-relapse mortality after marrow transplantation. Bone Marrow Transplant 15: 461–8
Iestra JA, Fibbe WE, Zwinderman AH, et al. (1999) Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies. Bone Marrow Transplant 23: 933–9
Iestra JA, Fibbe WE, Zwinderman AH, et al. (2002) Body weight recovery, eating difficultiers and compliance with dietary advice in the first year after stem cell transplantation: a prospective study. Bone Marrow Transplant 29: 417–24
Schulte C, Reinhardt W, Beelen D, et al. (1998) Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation. Bone Marrow Transplant 22: 1171–8
Trikha M, Corringham R, Klein B, Rossi JF, (2003) Targeted Anti-Interleukin-6 Monoclonal Antibody Therapy for Cancer. A Review of the Rationale, and Clinical Evidence. Clin Cancer Res 9: 4653–65
Hungria VT, Brandizil LI, Chiattone CS, et al. (1999) Metabolism of an artificial emulsion resembling chylomicrons in patients with multiple myeloma. Leuk Res. 23: 637–41
Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104: 3009–20
Goncalves RP, Hungria VT, Chiattone CS, et al. (2003) Metabolism of chylomicron-like emulsions in patients with Hodgkin’s and with non-Hodgkin’s lymphoma. Leuk Res 27: 147–53
Baker N, Gan-Elepano M, Guthrie BA, Mead JF (1989) Turnover and fate of plasma free fatty acids in briefly-fasted lymphoma-bearing mice. Lipids 24: 1028–34
Eagle DA, Gian V, Lauwers GY, et al. (2001) Gastroparesis following bone marrow transplantation. Bone Marrow Transplant 28: 59–62
Wolford JL, McDonald GB (1988) A problem-oriented approach to intestinal and liver disease after marrow transplantation. J Clin Gastroenterol 10 (4): 419–433
Keenan AM (1989) Nutritional support of the bone marrow transplant patient. Nurs Clin North Am 24: 383–93
Grigg AP, Angus PV, Hoyt R, Szer J (2003) The incidence, pathogenesis and natural history of steatorrhea after bone marrow transplantation. Bone Marrow Transplant 31: 701–3
Cox GJ, Matsui SM, Lo RS, et al. (1994) Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 107: 1398–1407
Jacobsohn DA, Margolis J, Doherty J, et al. (2002) Weight loss and malnutrition in patients with chronic graft-versus-host disease. Bone Marrow Transplant 29: 231–6
June CH, Thompson CB, Kennedy MS, et al. (1985) Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation 39: 620–4
Antila HM, Salo MS, Kirvela O, et al. (1992) Serum trace element concentrations and iron metabolism in allogeneic bone marrow transplant recipients. Ann Med 24: 55–9
Carlin A, Walker WA (1991) Rapid development of vitamin K deficiency in an adolescent boy receiving total parenteral nutrition following bone marrow transplantion. Nutr Rev 49: 179–83
Jonas CR, Puckett AB, Jones DP, et al. (2000) Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 72: 181–89
Szeluga DJ, Stuart RK, Brookmeyer R, et al. (1985) Energy requirements of parenterally fed bone marrow transplant recipients. J Parenter Enteral Nutr 9: 139–143
Cheney CL, Abson KG, Aker SN, et al. (1987) Body composition changes in marrow transplant recipients receiving total parenteral nutrition. Cancer 59: 1515–19
Schouten HC, Maragos D, Vose J, Armitage JO (1990) Diabetes mellitus or an impaired glucose tolerance as a potential complicating factor in patients treated with high-dose therapy and autologous bone marrow transplantation. Bone Marrow Transplant 6: 333–5
Smedmyr B, Wibell L, Simonsson B, Oberg G (1990) Impaired glucose tolerance after autologous bone marrow transplantation. Bone Marrow Transplant 6: 89–92
Nemunaitis J, Deeg HJ, Yee GC (1986) High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridaemia. Lancet 2: 744–5
Carreras E, Villamor N, Reverter JC, et al. (1989) Hypertriglyceridemia in bone marrow transplant recipients: another side effect of cyclosporine A. Bone Marrow Transplant 4: 385–388
Hutchinson ML, Clemans GW, Springmeyer SC, Flournoy N (1984) Energy expenditure estimation of recipients of marrow transplants. Cancer 54: 1734–8
Annis K (1986) Measured energy expenditure in bone marrow transplant patients. JPEN J Parenter Enteral Nutr 15 (suppl): 34S
Ringwald-Smith K, Williams R, Horwitz E, et al. (1998) Determination of energy expenditure in the bone marrow transplant patient. Nutr Clin Pract 13: 215–8
Chamouard Cogoluenhes V, Chambrier C, Michallet M, et al. (1998) Energy expenditure during allogeneic and autologous bone marrow transplantation. Clin Nutr 17: 253–257
Taveroff A, McArdle AH, Rybka WB (1991) Reducing parenteral energy and protein intake improves metabolic homeostasis after bone marrow transplantation. Am J Clin Nutr 54: 1087–92
Lenssen P, Bruemmer BA, Bowden RA, et al. (1998) Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am J Clin Nutr 67: 927–33
Muscaritoli M, Conversano L, Torelli GF, et al. (1998) Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogenic bone marrow transplantation. Transplantation 66: 610–6
Santos P, Lourenco R, Camilo ME, et al. (2001) Parenteral nutrition and cyclosporine: do lipids make a difference? A prospective randomized crossover trial. Clin Nutr 20: 31–6
Roberts I, Miller JE, Pineiro LA (2000) Is total parenteral nutrition beneficial in breast cancer after analogous marrow or blood transplantation? J Parenter Enteral Nutr 24 (suppl): S11
Weisdorf SA, Lysne J, Wind D, et al. (1987) Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 43: 833–8
Stern JM, Bruemmer B, Moinpour CM, et al. (2000) Impact of a randomized, controlled trial of liberal vs conservative hospital discharge criteria on energy, protein, and fluid intake in patients who received marrow transplants. J Am Diet Assoc 100: 1015–22
Charuhas PM, Fosberg KL, Bruemmer B, et al. (1997) A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation. JPEN J Parenter Enteral Nutr 21: 157–61
Ziegler TR, Bye RL, Persinger RL, et al. (1998) Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study. Am J Med Sci 315: 4–10
Piccirillo N, De Matteis S, Laurenti L, et al. (2003) Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica 88: 192–200
Scheltinga MR, Young LS, Benfell K, et al. (1991) Glutamine-enriched intravenous feedings attenuate extracellular fluid expansion after a standard stress. Ann Surg 4: 385–93
Schloerb PR, Amare M (1993) Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 17: 407–13
Ziegler TR, Young LS, Benfell K, et al. (1992) Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116: 821–8
Schloerb PR, Skikne BS (1999) Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. JPEN J Parenter Enteral Nutr 23: 117–22
van Zaanen HC, van der Lelie H, Timmer JG, et al. (1994). Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer 74: 2879–84
Scheid C, Hermann K, Kremer G, et al. (2004) Randomized, double-blind, controlled study of glycyl-glutamine-dipeptide in the parenteral nutrition of patients with acute leukemia under-going intensive chemotherapy. Nutrition 20: 249–54
Takastuka H, Takemoto Y, Iwata N, et al. (2001) Oral eicosapentaenoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 28: 769–74
Takastuka H, Takemoto Y, Yamada S, et al. (2002) Oral eicosapentenoic acid for acute colonic graft-versus-host disease after bone marrow transplantation. Drug Exp Clin Res 28: 121–5
Bendhamane B, Brandes I, Bhouris JH, et al. (1995) A comparison of medium-chain and long-chain triglycerides after bone marrow transplantation (BMT). International Symposium of Intensive Care and Emergency Medecine. March 21–24
Jimenez Jimenez FJ, Ortiz LC, Garcia Garmendia JL, et al. (1999) Prospective comparative study of different amino acid and lipid solutions in parenteral nutrition of patients undergoing bone marrow transplantation. Nutr Hosp 14: 57–66
Demirer S, Aydintug S, Ustun C, et al. (2000) Comparison of the efficacy of medium chain triglycerides with long chain triglycerides in total parenteral nutrition in patients with hematologic malignancies undergoing peripheral blood stem cell transplantation. Clin Nutr 19: 253–258
Lenssen P, Cheney CL, Aker SN, et al. (1987) Intravenous branched chain amino acid trial in marrow transplant recipients. J Parenter Enteral Nutr 11: 112–8
Papadopoulou A, MacDonald A, Williams MD et al. (1997) Enteral nutrition after bone marrow transplantation. Arch Dis Child 77: 131–7
Hopman GD, Peñna EG, le Cessie S, et al. (2003) Tube feeding and bone marrow transplantation. Med Pediatr Oncol 40: 375–9
Szeluga DJ, Stuart RK, Brookmeyer R, et al. (1987) Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 47 3309–16
Sefcick A, Anderton D, Byrne JL, et al. (2001) Naso-jejunal feeding in allogenic bone marrow transplant recipients: results of a pilot study. Bone Marrow Transplant 28: 1135–9
Seguy D, Micol JB, Berthon C, et al. (2003) Influence de la nutrition entérale précoce chez les allogreffés. Nutr Clin Metabol 17 (suppl 1): 33s
Roberts SR, Miller JE (1998) Success using PEG tubes in marrow transplant recipient. Nutr Clin Pract 13: 74–8
Sudre AC, Delarue R, Poisson-Salomon AS, et al. (2002) Evaluation des apports nutritionnels dans une unité de soins intensifs ďhématologie: impact ďun formulaire de nutrition thérapeutique. Nutr Clin Metabol 16 (suppl 1): 13s
Rights and permissions
Copyright information
© 2007 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Raynard, B. (2007). Nutrition et hémopathies malignes. In: Traité de nutrition artificielle de l’adulte. Springer, Paris. https://doi.org/10.1007/978-2-287-33475-7_58
Download citation
DOI: https://doi.org/10.1007/978-2-287-33475-7_58
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-33474-0
Online ISBN: 978-2-287-33475-7